Skip to content
Menu
Ranked #392

NowPatient

NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

Desk Score 59/100 (C) · Verified July 2026

Visit NowPatient ↗Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way.

Is NowPatient legit?

Only what NowPatient publishes and what we could check ourselves — nothing inferred. See the methodology.

Certification
On third-party certification, the site doesn't say.
Where it ships
The site doesn't say which states it serves.
Last checked
July 2026, against NowPatient's own pages.
Published price
NowPatient publishes a figure for semaglutide and tirzepatide — the qualifiers are in "What does NowPatient cost?" below.
What it sells
Brand-name medication as well as compounded, injectable and oral routes.
Licensing & trust
80/100 on the scored dimension of that name — one of the six in our published methodology.

Checks out as far as the figures go, with one caveat: every price NowPatient publishes carries a condition, so the number on the site is not the monthly bill.

What does NowPatient cost?

Each figure exactly as NowPatient publishes it, with the condition attached to it spelled out.

Semaglutide

$1,349/mo (brand Wegovy)

That is the FDA-approved brand product at $1,349 a month, which is a different medicine from compounded semaglutide at a different price.

Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for semaglutide — only flat month-to-month rates compete there.

Tirzepatide

$1,069/mo (brand Mounjaro, promotional rate)

That is the FDA-approved brand product at $1,069 a month, which is a different medicine from compounded tirzepatide at a different price.

Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for tirzepatide — only flat month-to-month rates compete there.

All figures as published on NowPatient's own site and read in July 2026. Prices change — confirm before you order.

Semaglutide
$1,349/mobrand-name
Tirzepatide
$1,069/mobrand-name
Coverage
Not listed on NowPatient's site (checked July 2026)
Brand-name
Yes
Verification
Prices as published on NowPatient's site — verified july 2026. Each figure's full condition is in “What does NowPatient cost?” below.

Line NowPatient up against its closest alternatives. Or go one-on-one: NowPatient vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency38/100
State access24/100
Molecule range95/100
Onboarding speed66/100
Support responsiveness83/100
Licensing & trust80/100

What we like

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where points come off

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

The bottom line — C

Best for: Brand-name GLP-1 access without a compounded route.

NowPatient ranks #392 of 542 providers scored — see #1, CoreAge Rx here.

Visit NowPatient ↗

Related reviews

Everyone else here (18)

Pricing and verification reflect NowPatient's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on NowPatient's site. Not medical advice; see our disclosure.

← Back to the ranking